Skip to main content
Daily Report

Daily Respiratory Research Analysis

05/31/2026
3 papers selected
47 analyzed

Analyzed 47 papers and selected 3 impactful papers.

Summary

Three impactful studies span mechanism, epidemiology, and comparative virology in respiratory science. A mechanistic paper reveals that β-hydroxybutyrylation of Zyxin suppresses pulmonary fibrosis via PI3K/AKT, suggesting a metabolic-epigenetic therapeutic angle. Nationwide evidence from Japan quantifies respiratory syncytial virus (RSV) burden attributable to ambient temperature, while a pig model dissects divergent immune paths between coronavirus and influenza.

Research Themes

  • Metabolic-epigenetic regulation of pulmonary fibrosis
  • Ambient temperature and RSV burden (climate–infectious disease dynamics)
  • Comparative respiratory virology and host immunity

Selected Articles

1. The β-hydroxybutyrylation of Zyxin ameliorates pulmonary fibrosis by inhibiting lung fibroblast activation through the PI3K/AKT pathway.

80Level VBasic/Mechanistic study
Respiratory research · 2026PMID: 42218444

In a bleomycin-induced mouse model of pulmonary fibrosis, Zyxin β-hydroxybutyrylation (Kbhb) is reduced, and restoring Kbhb with β-hydroxybutyrate mitigates fibrosis by modulating PI3K/AKT signaling. Site-specific loss of Zyxin Kbhb at K263 and genetic Zyxin deletion both attenuate collagen deposition and mortality, positioning metabolic protein acylation as a therapeutic lever in IPF.

Impact: This is the first demonstration that Zyxin Kbhb directly curbs fibrogenesis via PI3K/AKT, uncovering a mechanistically precise, druggable axis in IPF. It links metabolic signaling to focal adhesion biology and fibrosis resolution.

Clinical Implications: While preclinical, the data support evaluating β-hydroxybutyrate or Kbhb-enhancing strategies, and Zyxin/PI3K–AKT pathway modulation, as antifibrotic approaches in IPF. Human validation of Zyxin Kbhb status could enable biomarker-driven trials.

Key Findings

  • Lung tissue Kbhb is reduced in bleomycin-induced pulmonary fibrosis and restored by β-hydroxybutyrate.
  • Proteomics identifies decreased Kbhb at Zyxin K263 in IPF mice.
  • β-hydroxybutyrate or Zyxin knockout reduces fibrosis, collagen deposition, and mortality in vivo.
  • Transcriptomics implicate PI3K/AKT signaling as a mediator of the antifibrotic effect.

Methodological Strengths

  • Integrated multi-omics (transcriptomics, proteomics) with in vivo functional validation.
  • Use of genetic knockout and pharmacologic modulation to triangulate mechanism.

Limitations

  • Mouse bleomycin model may not fully recapitulate human IPF pathobiology.
  • Lack of human tissue validation for Zyxin Kbhb and off-target effects of β-hydroxybutyrate not fully explored.

Future Directions: Validate Zyxin Kbhb in human IPF lungs, map cell-type specificity, and test Kbhb-enhancing or Zyxin-targeted interventions in advanced preclinical models to enable biomarker-stratified early-phase trials.

Idiopathic pulmonary fibrosis (IPF) is a lethal interstitial lung disease with poorly understood pathogenesis. Here, we identify reduced lysine β-hydroxybutyrylation (Kbhb) of the focal adhesion protein Zyxin in bleomycin (BLM)-induced pulmonary fibrosis in mice. In a BLM-induced mouse model, we observe a significant reduction in lung tissue Kbhb levels, while β-hydroxybutyrate (β-OHB) supplementation restores Kbhb modification, there by mitigating fibrosis. Transcriptome profiling suggests that β-OHB exerts anti-fibrotic effects by modulating the PI3K/AKT pathway. Proteomic analysis further reveals a decrease in Kbhb modification at the K263 site of Zyxin in IPF mice. In vivo experiments demonstrate that Zyxin knockout or β-OHB treatment markedly alleviates fibrotic pathology and reduces collagen deposition as well as mouse mortality. This study is the first to elucidate the mechanism by which Zyxin Kbhb modification suppresses pulmonary fibrosis via the PI3K/AKT pathway, offering a novel metabolic modification-based therapeutic strategy for IPF.

2. Spatial heterogeneity in the burden of respiratory syncytial virus infection attributable to low and high ambient temperature in Japan: a nationwide time-stratified case-crossover analysis.

75.5Level IIICase-control
Respiratory research · 2026PMID: 42218525

Using 1.23 million RSV cases across Japan, a two-stage, nationwide time-stratified case-crossover and meta-analysis quantified that 21.32% of RSV cases are attributable to non-optimum temperature, with sustained moderate warmth driving a larger share than cold. Marked prefecture-level heterogeneity highlights the need for regionally tailored public health strategies.

Impact: This study delivers precise, policy-relevant attribution of RSV burden to ambient temperature at national scale, refining risk windows (lag 0–3 weeks) and emphasizing moderate warmth as a key driver.

Clinical Implications: RSV preparedness should incorporate temperature surveillance, with alerts and resource allocation tuned to periods of sustained moderate warmth; region-specific thresholds (MMT) can guide preventive measures and timing of prophylaxis.

Key Findings

  • Temperature–RSV association is U-shaped nationwide; non-optimum temperatures account for 21.32% of cases.
  • Moderate high temperatures contribute more to attributable burden than low temperatures; extreme temperatures contribute less.
  • High weekly mean temperatures over lag 0–3 weeks drive substantial risk with strong geographic heterogeneity across prefectures.

Methodological Strengths

  • Nationwide, 14-year dataset covering all 47 prefectures with over 1.2 million cases.
  • Robust two-stage design: time-stratified case-crossover with conditional quasi-Poisson and random-effects meta-analysis.

Limitations

  • Ecological design cannot capture individual-level susceptibility or interventions.
  • Residual confounding by co-circulating pathogens and reporting practices may persist.

Future Directions: Incorporate real-time meteorology with RSV surveillance and individual-level data to refine risk prediction; evaluate climate-adaptive timing for prophylaxis and hospital surge planning.

Respiratory syncytial virus (RSV) infection poses a considerable disease burden worldwide. Although multiple studies have estimated the short-term effects of ambient temperature on mortality and morbidity, the burden of RSV attributable to temperature is poorly characterized. This nationwide study aimed to quantify the total burden of RSV infection in Japan attributable to non-optimum ambient temperature conditions, and to partition this burden into contributions from low and high temperatures and from moderate and extreme components of non-optimum temperature. We collected weekly time-series data on the number of reported RSV cases and meteorological variables (mean temperature, relative humidity, wind speed, and sunshine duration) for all 47 Japanese prefectures from 2006 to 2019. An extended two-stage approach was used: First, a time-stratified case-crossover design fitted with conditional quasi-Poisson regression was used to estimate prefecture-specific associations. Second, multivariate random-effects meta-analysis was used to obtain pooled estimates. The number of attributable cases were estimated for temperatures above and below the optimum minimum morbidity temperature (MMT) and further categorized as moderate or extreme using the 2.5th and 97.5th percentiles as cutpoints. Data on 1,227,012 RSV cases reported during the study period were analyzed. The pooled exposure-response relationship between temperature and RSV incidence was U-shaped, with a higher RSV incidence at both low and high temperature levels. In most prefectures the MMT was between the 40th to 50th percentiles of the local temperature distribution. Overall, 21.32% (95% empirical confidence interval [eCI] 18.93% to 22.78%) of cases were attributable to non-optimum temperature, with marked geographic heterogeneity: from 8.24% (95% eCI: - 9.06-21.12%) in Akita, to 32.63% (95% eCI: 27.86-41.78%) in Kagoshima. A greater share of temperature-attributable cases was due to moderate high temperatures (12.27%, 95% eCI: 10.95-13.19%) than to low temperatures (9.05%, 95% eCI: 7.12-10.36%), whereas the contributions of extremely high and extremely low temperatures were relatively small. High weekly mean ambient temperatures over lag 0-3 weeks were associated with a substantial attributable risk of RSV infection. Public health efforts to reduce the RSV burden should take ambient temperature into account, paying particular attention to the impact of sustained, moderately warm conditions.

3. Pathogen-specific immune responses might underlie divergent outcomes of coronavirus and influenza infection in the natural porcine host.

73Level VBasic/Mechanistic study
Communications biology · 2026PMID: 42218309

In pigs, PRCV drives high viral load, prolonged shedding, robust T cell activation, and nasal microbiome shifts, whereas pH1N1 elicits rapid neutralizing antibodies with strong Tfh/GC B cell responses and broader early nasal diversity. Shared early interferon programs diverge into stromal–immune and vascular integrity pathways that shape lung pathology, underscoring pathogen-specific host–virus interactions.

Impact: By leveraging a natural large-animal host, this study dissects mechanistic differences in coronavirus versus influenza immunity across systemic, mucosal, and microbiome compartments, informing vaccine and therapeutic strategies.

Clinical Implications: Findings suggest pathogen-tailored immunization strategies: boosting Tfh/GC responses for coronaviruses and optimizing mucosal T cell responses where shedding is prolonged; nasal microbiome may serve as an adjunct biomarker/target.

Key Findings

  • PRCV induces higher viral load, prolonged shedding, and stronger systemic/mucosal T cell activation with memory B cell expansion.
  • pH1N1 triggers rapid neutralizing antibodies, robust Tfh and germinal center B cell responses, and broader early nasal microbial diversity.
  • Early shared interferon-stimulated gene activation diverges into stromal–immune and vascular integrity pathways shaping lung pathology.
  • Distinct nasal microbiome trajectories accompany pathogen-specific immunity.

Methodological Strengths

  • Translational large-animal (porcine) model with systemic, mucosal, cellular, and microbiome readouts.
  • Integrated immunophenotyping and transcriptional profiling to resolve pathway-level divergence.

Limitations

  • Sample sizes per group are not detailed in the abstract; power for subgroup analyses is unclear.
  • Porcine findings may not fully extrapolate to human disease or all viral strains.

Future Directions: Define correlates of protection across pathogens in pigs, test adjuvants/platforms that differentially enhance Tfh/GC versus mucosal T cell responses, and validate microbiome–immunity links longitudinally.

Coronaviruses and influenza A viruses are major respiratory pathogens with pandemic potential. Using pigs as a translational large-animal model, we compare the virulence, pathogenesis, and immune responses to porcine respiratory coronavirus (PRCV) and pandemic H1N1 2009 influenza virus (pH1N1). Here we show that PRCV induces higher viral load and prolonged viral shedding, stronger systemic and mucosal T cell activation, expansion of memory B cells, and distinct nasal microbiome changes. In contrast, pH1N1 results in rapid neutralising antibody production, robust Tfh and germinal centre B cell responses, and broader early nasal microbial diversity. Transcriptional responses to PRCV and pH1N1 infection start with the activation of shared interferon-stimulated genes but later diverge as pathways involving stromal-immune interactions and vascular integrity shapes lung pathology and subsequent immune responses. These findings demonstrate fundamental differences in coronavirus and influenza virus-host interactions and establish the pig as a powerful comparative model for studying respiratory virus pathogenesis and immunity.